Solumedrol: Clinical Trials

13 trials of Solumedrol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 2 terminated. 13 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 6, Unknown 5, Terminated 2
Phase 23Completed 1, Terminated 1, Unknown 1

Follow Solumedrol: new trials by email Literature Review of Solumedrol trials Research Report on Solumedrol

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Solumedrol - Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)
Phase 3UnknownSohag University2152024-05-012024-06-17
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Solumedrol - Active Rheumatoid Arthritis
Phase 3UnknownSohag University2682024-05-012024-06-13
The Prospective Evaluation of Peri-Operative Glucocorticoid Use in the Management of Cervicofacial Infections of Odontogenic Origin
Methylprednisolone - Odontogenic Infection of Jaw (Disorder)
Phase 2 / Phase 3CompletedUniversity of Manitoba292022-06-222023-07-21
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
Dexamethasone 2 MG/ML, Methylprednisolone Injection - Covid 19 Disease
Phase 3CompletedFatima Memorial Hospital1002020-05-302020-10-27
Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
Rituximab, endoxan, Methylprednisolone - ANCA Associated Vasculitis
Phase 3UnknownLeiden University Medical Center1002019-05-032023-12-14
Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
SoluMatrix™ Abiraterone Acetate, Methylprednisolone - Prostate Cancer
Phase 3CompletedGU Research Network, LLC22016-09-012020-07-22
Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
Antox tablets(Mepaco), drug therapy for ITP - Immune Thrombocytopenia
Phase 2 / Phase 3UnknownAin Shams University1002013-03-012013-01-09
Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
Rituximab, Methylprednisolone, Cyclophosphamide - Glomerulonephritis, Membranous
Phase 3UnknownAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia762012-01-012019-05-20
Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone
Methylprednisolone, ACTH, IV placebo - Multiple Sclerosis
Phase 2 / Phase 3TerminatedNeurologique Foundation, Inc.302009-10-012016-03-22
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Allogeneic HSCT, Anti-thymocyte globulin (ATG), Cyclosporine (CSP) - Leukemia, Myeloid, Leukemia
Phase 3TerminatedStanford University582007-08-012019-09-24
OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
mycophenolate mofetil, anti-IL-2R, methylprednisolone - Kidney Transplantation
Phase 3CompletedHoffmann-La Roche2522006-05-012015-11-11
A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
Methylprednisolone and IVIG, Placebo and IVIG - Immune Thrombocytopenic Purpura
Phase 3CompletedThe Hospital for Sick Children322005-08-012016-05-09
Steroids and Azathioprine in Advanced IgAN
methylprednisolone, azathioprine, prednisone - IgA Nephropathy, Chronic Kidney Disease
Phase 3CompletedA. Manzoni Hospital461999-12-012011-07-13

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Arthritis, Juvenile (1)  ·  COVID-19 (1)  ·  Glomerulonephritis, IGA (1)  ·  Glomerulonephritis, Membranous (1)  ·  Intracranial Hemorrhages (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Sclerosis (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Proteinuria (1)  ·  Recurrence (1)

Sponsors

Sohag University (2)  ·  A. Manzoni Hospital (1)  ·  Ain Shams University (1)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Fatima Memorial Hospital (1)  ·  GU Research Network, LLC (1)  ·  Hoffmann-La Roche (1)  ·  Leiden University Medical Center (1)  ·  Neurologique Foundation, Inc. (1)  ·  Stanford University (1)  ·  The Hospital for Sick Children (1)  ·  University of Manitoba (1)

Countries

Egypt (3)  ·  United States (3)  ·  Canada (2)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Pakistan (1)

Top investigators

Arzinda F Syeda, MBBS, FCPS (1)  ·  Daniel Kantor, MD (1)  ·  Khurshid A Khan, MBBS, FACM (1)  ·  Manuel Carcao, MD (1)  ·  Mohsen S Elalfy, professor (1)  ·  Robert Lowsky (1)  ·  Ryan McCoy, DDS (1)  ·  Victor Blanchette, MD (1)

Results publications

PMID 31806605, PMID 32282882, PMID 33649098, PMID 34778952, PMID 36130755